HHS Slams Ex-InterMune CEO's Challenge To Program Ban

Law360, New York (August 29, 2013, 4:21 PM EDT) -- The U.S. Department of Health and Human Services on Wednesday hit back at a challenge by the former CEO of InterMune Inc. to his five-year exclusion from federal health programs following his conviction of fraudulently marketing the drug Actimmune, telling a California federal court the exclusion was legally valid.

Former InterMune CEO W. Scott Harkonen had taken too narrow a view of what counts as being “in connection with the delivery of a health care item or service” under federal health care law, with his conviction...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Harkonen v. Sebelius et al


Case Number

4:13-cv-00071

Court

California Northern

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Judge

Phyllis J. Hamilton

Date Filed

January 6, 2013

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.